Related Experiment Video
Updated: Jun 30, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Outcomes of carotid revascularization in patients with chronic kidney disease
Gurushankar Govindarajan1, Georges Saab, Adam Whaley-Connell
1Department of Internal Medicine, Division of Cardiology, University of Missouri-Columbia School of Medicine, Columbia, MO 65212, USA. govindarajang@health.missouri.edu
Insights
Patients with chronic kidney disease (CKD) face higher risks of stroke. Carotid revascularization may help, but more research is needed specifically for CKD patients.
Area of Science:
- Nephrology
- Neurology
- Cardiovascular Medicine
Background:
- Chronic kidney disease (CKD) significantly elevates cardiovascular disease (CVD) risk, including cerebrovascular accidents (CVAs).
- Extracranial carotid artery disease is a major cause of ischemic stroke, accounting for about 25% of cases.
- Carotid revascularization procedures like endarterectomy and angioplasty/stenting are proven CVA risk reducers in general populations.
Purpose of the Study:
- To highlight the limited evidence for carotid revascularization in patients with chronic kidney disease.
- To emphasize the need for large-scale clinical trials focused on CKD populations undergoing carotid revascularization.
Main Methods:
- Review of existing literature on carotid artery disease management in CKD.
- Analysis of the exclusion criteria in major carotid revascularization trials.
- Identification of evidence gaps and expert opinion reliance.
Main Results:
- Large randomized trials on carotid revascularization have largely excluded patients with kidney failure.
- Current management strategies for carotid disease in CKD rely on small studies and expert consensus.
- There is a significant lack of robust clinical trial data for this specific patient group.
Conclusions:
- Carotid revascularization techniques are effective but understudied in CKD patients.
- Urgent need for large clinical trials to optimize carotid revascularization therapies for individuals with CKD.
- Improved understanding and techniques are crucial for reducing CVA risk in CKD patients.
Abstract:
Chronic kidney disease (CKD) carries an increased risk for cardiovascular disease (CVD) including cerebrovascular accidents (CVAs). There are multiple etiologies for CVA, and among them extracranial carotid artery disease accounts for approximately 25% of ischemic strokes. It has been shown that carotid revascularization by carotid endarterectomy and carotid artery angioplasty and stenting can decrease the risk of CVA in appropriately selected population with carotid artery disease. Both these techniques of carotid revascularization have been shown to be safe and clinically effective in many large multicentered randomized clinical trials. However, most of these large trials have predominately excluded the patients with kidney failure. Most of the evidence for the management of carotid disease in CKD is based on small clinical trials and expert opinions. There is an urgent need to conduct large clinical trials in patients with CKD to enable better understanding and to improve techniques of various carotid revascularization therapies in CKD patients.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury III: Clinical Manifestations
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
